Japanese ADNI ProjectJapanese ADNI project January 2011, PI Takeshi Iwatsubo, Univ. Tokyo Background: In view of the upcoming clinical trials of disease-modifying drugs for Alzheimer’s disease (AD), there is a compelling need for the establishment of a complete set of surrogate biomarkers that reflect and predict the progression of AD, especially conversion from mild cognitive impairment (MCI) to AD. For this purpose
